The PTH/PTHrP receptor can delay chondrocyte hypertrophy in vivo without activating phospholipase C
The PTH/PTHrP receptor can delay chondrocyte hypertrophy in vivo without activating phospholipase C
复制标题
DOI:
10.1016/s1534-5807(02)00218-6
复制
发表时间:
2002-08-01
影响因子:
11.8
通讯作者:
Kronenberg, HM
中科院分区:
文献类型:
--
作者:
Guo, J;Chung, U;Kronenberg, HM
One G protein-coupled receptor (GPCR) can activate more than one G protein, but the physiologic importance of such activation has not been demonstrated in vivo. We have generated mice expressing exclusively a mutant form of the PTH/PTHrP receptor (DSEL) that activates adenylyl cyclase normally but not phospholipase C (PLC). DSEL mutant mice exhibit abnormalities in embryonic endochondral bone development, including delayed ossification and increased chondrocyte proliferation. Analysis of the differentiation of embryonic metatarsals in vitro shows that PTH(1-34) and forskolin inhibit, whereas active phorbol ester stimulates, hypertrophic differentiation. Thus, PLC signaling via the PTH/PTHrP receptor normally slows the proliferation and hastens the differentiation of chondrocytes, actions that oppose the dominant effects of PTH/PTHrP receptors and that involve cAMP-dependent signaling pathways.